Rebeca Calado

Rebeca Calado

Auto-generated profile, based on publicly available information

Rebeca Calado

Department of Dermatology Coimbra Hospital and University Centre Coimbra Portugal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
MBMariana Batista
Mariana Batista
RCRebeca Calado
Rebeca Calado
FGFrancisco Gil
Francisco Gil
JCJosé C. Cardoso
José C. Cardoso
OTOscar Tellechea
Oscar Tellechea
MGMargarida Gonçalo
Margarida Gonçalo

7 April 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
FAF. Alves
F. Alves
RCR. Calado
R. Calado
MRM. Relvas
M. Relvas
TGT. Gomes
T. Gomes
MGM. Gonçalo
M. Gonçalo

17 February 2022 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
TGTiago Fernandes Gomes
Tiago Fernandes Gomes
RCRebeca Calado
Rebeca Calado
AMAna Luísa Matos
Ana Luísa Matos
MGMargarida Gonçalo
Margarida Gonçalo

17 March 2021 in Journal of Paediatrics and Child Health
Verified
Journal Article
Open access
PDF file
RCRebeca Calado
Rebeca Calado
JCJoana Calvão
Joana Calvão
SPSofia Pereira
Sofia Pereira
LRLeonor Ramos
Leonor Ramos
Click on the article title to read more.

4 July 2021 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
AMAna Luísa Matos
Ana Luísa Matos
JCJóni Carvalho
Jóni Carvalho
RCRebeca Calado
Rebeca Calado
TGTiago Gomes
Tiago Gomes
LRLeonor Ramos
Leonor Ramos
MGMargarida Gonçalo
Margarida Gonçalo

17 October 2021 in Journal of the Portuguese Society of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
TGTiago Fernandes Gomes
Tiago Fernandes Gomes
RCRebeca Calado
Rebeca Calado
MGMargarida Gonçalo
Margarida Gonçalo
Impaired skin barrier is one of the hallmarks of atopic dermatitis (AD), with abnormalities in the cornified envelope, lipid lamellae, tight junctions and cutaneous microbiome. These findings are also present in nonlesional skin of AD individuals, suggesting that epidermal barrier defects may be the initial step towards the development of AD and eventually other atopic diseases (atopic march). It is currently known that pathophysiology of AD involves an interplay between this dysfunctional skin barrier and a predominantly type 2 skewed innate and adaptive immune responses, which further disrupt the skin barrier through type 2 cytokines. In this setting, there is enhanced penetration of environmental and food allergens through a deficient barrier, leading to an increased susceptibility to sensitization. During the sensitization process, thymic stromal lymphopoietin (TSLP) polarizes skin dendritic cells to a T-helper 2 response, and TSLP seems to be a key cytokine in the sensitization of food allergy, allergic asthma and rhinitis. In this review, the authors describe the current knowledge of the pathophysiology of the epidermal barrier, its disruption in AD and how it may be involved in the development of atopic comorbidities and the role of barrier repair therapy on the prevention of the atopic march progression.